Itron Announces Second Quarter 2021 Financial Results and Updated Full-Year 2021 Guidance

August 5, 2021

LIBERTY LAKE, Wash.--(BUSINESS WIRE)--Aug. 5, 2021-- Itron, Inc. (NASDAQ:ITRI) announced today financial results for its second quarter ended June 30, 2021. Key results for the quarter include (compared with the second quarter of 2020):

  • Revenue of $489 million, compared with $510 million;
  • Gross margin of 30.6%; compared with 27.2%;
  • GAAP net loss of $(33) million, compared with $(63) million;
  • GAAP loss per share (EPS) of $(0.73), compared with $(1.56);
  • Non-GAAP diluted EPS of $0.28, compared with $0.03;
  • Adjusted EBITDA of $36 million, compared with $31 million;
  • Free cash flow of $64 million compared with $(10) million; and
  • Total backlog of $3.5 billion, compared with $2.9 billion.

"While we saw demand recovery in the second quarter, our results were negatively impacted by component constraints, which affected both our ability to meet customer demand and our cost structure," said Tom Deitrich, Itron's president and chief executive officer.

"We anticipate that the component supply will remain constrained in the second half of the year and into 2022. Despite these near-term challenges, we remain positive on the overall outlook for the company as we continued to execute on our strategy and see demand recovery from the COVID-19 pandemic. With our strong balance sheet, I believe we are well positioned to drive our business forward."

Summary of Second Quarter Consolidated Financial Results
(All comparisons made are against the prior year period unless otherwise noted)

Revenue
Total second quarter revenue decreased 4% to $489 million, or 7%, excluding the impact of changes in foreign currency exchange rates. The decrease was primarily due to component constraints, which negatively impacted revenue by approximately $40-$50 million.

Device Solutions revenue increased 26% and Outcomes revenue increased 10%. Networked Solutions revenue decreased 18% with the majority of the decline due to component constraints in the quarter.

Gross Margin
Consolidated company gross margin of 30.6% increased 340 basis points from the prior year, primarily due to product mix and the reduced impact of COVID-19 related manufacturing inefficiencies that impacted 2020.

Operating Expenses and Operating Income
GAAP operating expenses of $157 million decreased $27 million from the prior year, primarily due to lower loss on sale of business compared with the prior year. Non-GAAP operating expenses of $123 million increased $5 million from the prior year due to higher sales, general and administrative expenses in part due to higher variable compensation.

GAAP operating loss of $(7) million was $38 million lower than the prior year due to lower operating expenses. Non-GAAP operating income of $27 million was $7 million higher than last year due to higher gross profit.

Net Income (loss) and Earnings per Share
The net loss attributable to Itron, Inc. for the quarter was $(33) million, or $(0.73) per diluted share, an improvement from a net loss of $(63) million, or $(1.56) per diluted share in 2020. The improvement was driven by a lower GAAP operating loss related to the 2020 sale of our Latin America operations.

Non-GAAP net income, which excludes certain charges including amortization of intangible assets, amortization of debt placement fees, debt extinguishment, restructuring, loss on sale of business, corporate transition cost, acquisition and integration related expenses and the income tax effect of those adjustments, was $13 million, or $0.28 per diluted share, compared with $1 million, or $0.03 per diluted share, in 2020. The higher year over year results were due to higher non-GAAP operating income and lower interest expense.

Cash Flow
Net cash provided by operating activities was $73 million in the second quarter compared with $7 million in the same quarter of 2020. Free cash flow was $64 million in the second quarter compared with $(10) million in the prior year. The year over year improvement in cash flow was primarily due to improved working capital and lower interest expense.

Other Measures

Total backlog was a record $3.5 billion and 12-month backlog was $1.4 billion, compared with $2.9 billion and $1.3 billion, respectively, in the prior year. Bookings in the quarter totaled $596 million.

Financial Guidance Update

Itron's guidance for the full year 2021 has been updated to reflect the impact of component constraints and is as follows:

  • Revenue between $2.05 to $2.15 billion vs. previous guidance of $2.23 to $2.33 billion
  • Non-GAAP diluted EPS between $1.00 to $1.50 vs. previous guidance of $2.30 to $2.70

The guidance assumes a Euro to U.S. dollar foreign currency exchange rate of 1.20 on average in the second half of 2021, average fully diluted shares outstanding of approximately 44.7 million for the full year, non-GAAP effective tax rate for the full year of approximately 32-34% and total non-GAAP interest expense of approximately $11 million for the full year. The updated guidance also assumes that component constraints lowers revenue by $150 to $200 million. A reconciliation of forward-looking non-GAAP diluted EPS to the GAAP diluted EPS has not been provided because we are unable to predict with reasonable certainty the potential amount or timing of restructuring and acquisition and integration-related expenses and their related tax effects without unreasonable effort. These items are uncertain, depend on various factors and could have a material impact on GAAP results for the guidance period.

Earnings Conference Call

Itron will host a conference call to discuss the financial results and guidance contained in this release at 10 a.m. EDT on Aug. 5, 2021. The call will be webcast in a listen-only mode. Webcast information and conference call materials will be made available 10 minutes before the start of the call and will be accessible on Itron’s website at http://investors.itron.com/events.cfm. A replay of the audio webcast will be made available at http://investors.itron.com/events.cfm. A telephone replay of the conference call will be available through Aug. 10, 2021. To access the telephone replay, dial 888-203-1112 or 719-457-0820 and enter passcode 3115180.

About Itron

Itron® enables utilities and cities to safely, securely and reliably deliver critical infrastructure services to communities in more than 100 countries. Our portfolio of smart networks, software, services, meters and sensors helps our customers better manage electricity, gas and water resources for the people they serve. By working with our customers to ensure their success, we help improve the quality of life, ensure the safety and promote the well-being of millions of people around the globe. Itron is dedicated to creating a more resourceful world. Join us: www.itron.com.

Itron® is a registered trademark of Itron, Inc. All third-party trademarks are property of their respective owners and any usage herein does not suggest or imply any relationship between Itron and the third party unless expressly stated.

Cautionary Note Regarding Forward Looking Statements

This release contains, and our officers and representatives may from time to time make, "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are neither historical factors nor assurances of future performance. These statements are based on our expectations about, among others, revenues, operations, financial performance, earnings, liquidity, earnings per share, cash flows and restructuring activities including headcount reductions and other cost savings initiatives. This document reflects our current strategy, plans and expectations and is based on information currently available as of the date of this release. When we use words such as "expect", "intend", "anticipate", "believe", "plan", "goal", "seek", "project", "estimate", "future", "strategy", "objective", "may", "likely", "should", "will", "will continue", and similar expressions, including related to future periods, they are intended to identify forward-looking statements. Forward-looking statements rely on a number of assumptions and estimates. Although we believe the estimates and assumptions upon which these forward-looking statements are based are reasonable, any of these estimates or assumptions could prove to be inaccurate and the forward-looking statements based on these estimates and assumptions could be incorrect. Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Actual results and trends in the future may differ materially from those suggested or implied by the forward-looking statements depending on a variety of factors. Therefore, you should not rely on any of these forward-looking statements. Some of the factors that we believe could affect our results include our ability to execute on our restructuring plan, our ability to achieve estimated cost savings, the rate and timing of customer demand for our products, rescheduling of current customer orders, changes in estimated liabilities for product warranties, adverse impacts of litigation, changes in laws and regulations, our dependence on new product development and intellectual property, future acquisitions, changes in estimates for stock-based and bonus compensation, increasing volatility in foreign exchange rates, international business risks, uncertainties caused by adverse economic conditions, including, without limitation those resulting from extraordinary events or circumstances such as the COVID-19 pandemic and other factors that are more fully described in Part I, Item 1A: Risk Factors included in our 2020 Annual Report and other reports on file with the SEC. We undertake no obligation to update or revise any forward-looking statement, whether written or oral.

The impact caused by the ongoing COVID-19 pandemic includes uncertainty as to the duration, spread, severity, and any resurgence of the COVID-19 pandemic including other factors contributing to infection rates, such as reinfection or mutation of the virus, the effectiveness or widespread availability and application of vaccines, the duration and scope of related government orders and restrictions, impact on overall demand, impact on our customers’ businesses and workforce levels, disruptions of our business and operations, including the impact on our employees, limitations on, or closures of, our facilities, or the business and operations of our customers or suppliers. Our estimates and statements regarding the impact of COVID-19 are made in good faith to provide insight to our current and future operating and financial environment and any of these may materially change due to factors outside our control. For more information on risks associated with the COVID-19 pandemic, please see our risk in Part I, Item 1A: Risk Factors in our 2020 Annual Report.

Non-GAAP Financial Information

To supplement our consolidated financial statements, which are prepared in accordance with accounting principles generally accepted in the United States (GAAP), we use certain adjusted or non-GAAP financial measures, including non-GAAP operating expense, non-GAAP operating income, non-GAAP net income, non-GAAP diluted earnings per share (EPS), adjusted EBITDA, adjusted EBITDA margin, constant currency, and free cash flow. We provide these non-GAAP financial measures because we believe they provide greater transparency and represent supplemental information used by management in its financial and operational decision making. We exclude certain costs in our non-GAAP financial measures as we believe the net result is a measure of our core business. We believe these measures facilitate operating performance comparisons from period to period by eliminating potential differences caused by the existence and timing of certain expense items that would not otherwise be apparent on a GAAP basis. Non-GAAP performance measures should be considered in addition to, and not as a substitute for, results prepared in accordance with GAAP. We strongly encourage investors and shareholders to review our financial statements and publicly-filed reports in their entirety and not to rely on any single financial measure. Our non-GAAP financial measures may be different from those reported by other companies.

ITRON, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

 

(Unaudited, in thousands, except per share data)

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2021

 

2020

 

2021

 

2020

Revenues

 

 

 

 

 

 

 

 

Product revenues

 

$

411,719

 

 

$

438,985

 

 

$

854,523

 

 

$

967,122

 

Service revenues

 

77,693

 

 

70,609

 

 

154,463

 

 

140,887

 

Total revenues

 

489,412

 

 

509,594

 

 

1,008,986

 

 

1,108,009

 

Cost of revenues

 

 

 

 

 

 

 

 

Product cost of revenues

 

295,064

 

 

329,293

 

 

602,755

 

 

713,974

 

Service cost of revenues

 

44,473

 

 

41,784

 

 

89,312

 

 

83,952

 

Total cost of revenues

 

339,537

 

 

371,077

 

 

692,067

 

 

797,926

 

Gross profit

 

149,875

 

 

138,517

 

 

316,919

 

 

310,083

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

Sales, general and administrative

 

74,144

 

 

69,538

 

 

150,136

 

 

150,036

 

Research and development

 

48,763

 

 

48,994

 

 

100,490

 

 

102,775

 

Amortization of intangible assets

 

8,997

 

 

11,140

 

 

17,970

 

 

22,305

 

Restructuring

 

192

 

 

(2,683

)

 

(1,788

)

 

(2,931

)

Loss on sale of business

 

24,711

 

 

56,915

 

 

26,103

 

 

56,915

 

Total operating expenses

 

156,807

 

 

183,904

 

 

292,911

 

 

329,100

 

 

 

 

 

 

 

 

 

 

Operating income (loss)

 

(6,932

)

 

(45,387

)

 

24,008

 

 

(19,017

)

Other income (expense)

 

 

 

 

 

 

 

 

Interest income

 

432

 

 

1,258

 

 

974

 

 

1,811

 

Interest expense

 

(14,004

)

 

(11,684

)

 

(24,479

)

 

(22,961

)

Other income (expense), net

 

(12,157

)

 

(1,873

)

 

(14,923

)

 

(807

)

Total other income (expense)

 

(25,729

)

 

(12,299

)

 

(38,428

)

 

(21,957

)

 

 

 

 

 

 

 

 

 

Loss before income taxes

 

(32,661

)

 

(57,686

)

 

(14,420

)

 

(40,974

)

Income tax benefit (provision)

 

216

 

 

(4,801

)

 

(4,445

)

 

(12,351

)

Net loss

 

(32,445

)

 

(62,487

)

 

(18,865

)

 

(53,325

)

Net income attributable to noncontrolling interests

 

678

 

 

315

 

 

1,655

 

 

793

 

Net loss attributable to Itron, Inc.

 

$

(33,123

)

 

$

(62,802

)

 

$

(20,520

)

 

$

(54,118

)

 

 

 

 

 

 

 

 

 

Net loss per common share - Basic

 

$

(0.73

)

 

$

(1.56

)

 

$

(0.47

)

 

$

(1.35

)

Net loss per common share - Diluted

 

$

(0.73

)

 

$

(1.56

)

 

$

(0.47

)

 

$

(1.35

)

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding - Basic

 

45,142

 

 

40,216

 

 

43,344

 

 

40,130

 

Weighted average common shares outstanding - Diluted

 

45,142

 

 

40,216

 

 

43,344

 

 

40,130

 

ITRON, INC.

SEGMENT INFORMATION

 

(Unaudited, in thousands)

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2021

 

2020

 

2021

 

2020

Product revenues

 

 

 

 

 

 

 

 

Device Solutions

 

$

160,647

 

 

$

126,950

 

 

$

330,978

 

 

$

327,118

 

 

Networked Solutions

 

235,167

 

 

300,351

 

 

493,870

 

 

615,788

 

 

Outcomes

 

15,905

 

 

11,684

 

 

29,675

 

 

24,216

 

 

Total Company

 

$

411,719

 

 

$

438,985

 

 

$

854,523

 

 

$

967,122

 

 

 

 

 

 

 

 

 

 

 

Service revenues

 

 

 

 

 

 

 

 

Device Solutions

 

$

2,320

 

 

$

2,215

 

 

$

4,770

 

 

$

4,326

 

 

Networked Solutions

 

29,891

 

 

24,129

 

 

59,502

 

 

49,537

 

 

Outcomes

 

45,482

 

 

44,265

 

 

90,191

 

 

87,024

 

 

Total Company

 

$

77,693

 

 

$

70,609

 

 

$

154,463

 

 

$

140,887

 

 

 

 

 

 

 

 

 

 

 

Total revenues

 

 

 

 

 

 

 

 

Device Solutions

 

$

162,967

 

 

$

129,165

 

 

$

335,748

 

 

$

331,444

 

 

Networked Solutions

 

265,058

 

 

324,480

 

 

553,372

 

 

665,325

 

 

Outcomes

 

61,387

 

 

55,949

 

 

119,866

 

 

111,240

 

 

Total Company

 

$

489,412

 

 

$

509,594

 

 

$

1,008,986

 

 

$

1,108,009

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

 

 

 

 

 

 

 

Device Solutions

 

$

30,452

 

 

$

11,948

 

 

$

62,748

 

 

$

44,315

 

 

Networked Solutions

 

95,953

 

 

108,323

 

 

208,712

 

 

230,073

 

 

Outcomes

 

23,470

 

 

18,246

 

 

45,459

 

 

35,695

 

 

Total Company

 

$

149,875

 

 

$

138,517

 

 

$

316,919

 

 

$

310,083

 

 

 

 

 

 

 

 

 

 

 

Operating income (loss)

 

 

 

 

 

 

 

 

Device Solutions

 

$

19,988

 

 

$

(1,120

)

 

$

41,689

 

 

$

17,078

 

 

Networked Solutions

 

64,630

 

 

77,382

 

 

143,921

 

 

166,062

 

 

Outcomes

 

12,537

 

 

9,226

 

 

22,873

 

 

17,424

 

 

Corporate unallocated

 

(104,087

)

 

(130,875

)

 

(184,475

)

 

(219,581

)

 

Total Company

 

$

(6,932

)

 

$

(45,387

)

 

$

24,008

 

 

$

(19,017

)

 

ITRON, INC.

CONSOLIDATED BALANCE SHEETS

 

(Unaudited, in thousands)

 

June 30, 2021

 

December 31, 2020

ASSETS

 

 

 

 

Current assets

 

 

 

 

Cash and cash equivalents

 

$

207,131

 

 

$

206,933

 

Accounts receivable, net

 

336,071

 

 

369,828

 

Inventories

 

179,347

 

 

182,377

 

Other current assets

 

120,351

 

 

171,124

 

Total current assets

 

842,900

 

 

930,262

 

 

 

 

 

 

Property, plant, and equipment, net

 

196,209

 

 

207,816

 

Deferred tax assets, net

 

99,297

 

 

76,142

 

Other long-term assets

 

41,293

 

 

51,656

 

Operating lease right-of-use assets, net

 

72,059

 

 

76,276

 

Intangible assets, net

 

113,672

 

 

132,955

 

Goodwill

 

1,123,155

 

 

1,131,916

 

Total assets

 

$

2,488,585

 

 

$

2,607,023

 

 

 

 

 

 

LIABILITIES AND EQUITY

 

 

 

 

Current liabilities

 

 

 

 

Accounts payable

 

$

175,546

 

 

$

215,639

 

Other current liabilities

 

70,525

 

 

72,591

 

Wages and benefits payable

 

103,642

 

 

86,249

 

Taxes payable

 

14,235

 

 

15,804

 

Current portion of debt

 

 

 

18,359

 

Current portion of warranty

 

20,299

 

 

28,329

 

Unearned revenue

 

130,118

 

 

112,928

 

Total current liabilities

 

514,365

 

 

549,899

 

 

 

 

 

 

Long-term debt, net

 

479,034

 

 

902,577

 

Long-term warranty

 

15,911

 

 

13,061

 

Pension benefit obligation

 

116,666

 

 

119,457

 

Deferred tax liabilities, net

 

1,832

 

 

1,921

 

Operating lease liabilities

 

62,785

 

 

66,823

 

Other long-term obligations

 

97,334

 

 

113,012

 

Total liabilities

 

1,287,927

 

 

1,766,750

 

 

 

 

 

 

Equity

 

 

 

 

Common stock

 

1,775,315

 

 

1,389,419

 

Accumulated other comprehensive loss, net

 

(145,172

)

 

(138,526

)

Accumulated deficit

 

(454,865

)

 

(434,345

)

Total Itron, Inc. shareholders' equity

 

1,175,278

 

 

816,548

 

Noncontrolling interests

 

25,380

 

 

23,725

 

Total equity

 

1,200,658

 

 

840,273

 

Total liabilities and equity

 

$

2,488,585

 

 

$

2,607,023

 

ITRON, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

(Unaudited, in thousands)

 

Six Months Ended June 30,

 

 

2021

 

2020

Operating activities

 

 

 

 

Net loss

 

$

(18,865

)

 

$

(53,325

)

Adjustments to reconcile net loss to net cash provided by operating activities:

 

 

 

 

Depreciation and amortization

 

42,919

 

 

48,230

 

Non-cash operating lease expense

 

8,647

 

 

9,909

 

Stock-based compensation

 

12,586

 

 

15,581

 

Amortization of prepaid debt fees

 

4,315

 

 

2,013

 

Deferred taxes, net

 

(2,942

)

 

5,904

 

Loss on sale of business

 

26,103

 

 

56,915

 

Loss on extinguishment of debt

 

10,000

 

 

 

Restructuring, non-cash

 

878

 

 

(1,146

)

Other adjustments, net

 

13,913

 

 

287

 

Changes in operating assets and liabilities, net of sale of business:

 

 

 

 

Accounts receivable

 

29,549

 

 

52,031

 

Inventories

 

70

 

 

(16,529

)

Other current assets

 

22,164

 

 

(7,861

)

Other long-term assets

 

6,207

 

 

(3,919

)

Accounts payable, other current liabilities, and taxes payable

 

(43,115

)

 

(76,144

)

Wages and benefits payable

 

17,815

 

 

(11,145

)

Unearned revenue

 

17,106

 

 

23,099

 

Warranty

 

(4,744

)

 

(8,417

)

Other operating, net

 

(19,926

)

 

(9,697

)

Net cash provided by operating activities

 

122,680

 

 

25,786

 

 

 

 

 

 

Investing activities

 

 

 

 

Net proceeds (payments) related to the sale of business

 

3,142

 

 

(3,630

)

Acquisitions of property, plant, and equipment

 

(20,476

)

 

(29,049

)

Other investing, net

 

2,819

 

 

3,520

 

Net cash used in investing activities

 

(14,515

)

 

(29,159

)

 

 

 

 

 

Financing activities

 

 

 

 

Proceeds from borrowings

 

460,000

 

 

400,000

 

Payments on debt

 

(915,000

)

 

 

Issuance of common stock

 

3,255

 

 

4,183

 

Proceeds from common stock offering

 

389,419

 

 

 

Proceeds from sale of warrants

 

45,349

 

 

 

Purchases of convertible note hedge contracts

 

(84,139

)

 

 

Prepaid debt fees

 

(12,021

)

 

(184

)

Other financing, net

 

4,993

 

 

(2,036

)

Net cash (used in) provided by financing activities

 

(108,144

)

 

401,963

 

 

 

 

 

 

Effect of foreign exchange rate changes on cash and cash equivalents

 

177

 

 

(3,671

)

Increase in cash and cash equivalents

 

198

 

 

394,919

 

Cash and cash equivalents at beginning of period

 

206,933

 

 

149,904

 

Cash and cash equivalents at end of period

 

$

207,131

 

 

$

544,823

 

About Non-GAAP Financial Measures

The accompanying press release contains non-GAAP financial measures. To supplement our consolidated financial statements, which are prepared in accordance with GAAP, we use certain non-GAAP financial measures, including non-GAAP operating expense, non-GAAP operating income, non-GAAP net income, non-GAAP diluted EPS, adjusted EBITDA, free cash flow, and constant currency. The presentation of this financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP, and other companies may define such measures differently. For more information on these non-GAAP financial measures, please see the table captioned Reconciliations of Non-GAAP Financial Measures to the Most Directly Comparable GAAP Financial Measures.

We use these non-GAAP financial measures for financial and operational decision making and/or as a means for determining executive compensation. Management believes that these non-GAAP financial measures provide meaningful supplemental information regarding our performance and ability to service debt by excluding certain expenses that may not be indicative of our recurring core operating results. These non-GAAP financial measures facilitate management's internal comparisons to our historical performance, as well as comparisons to our competitors' operating results. Our executive compensation plans exclude non-cash charges related to amortization of intangibles and certain discrete cash and non-cash charges, such as acquisition and integration related expenses, loss on sale of business, or restructuring charges. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting and analyzing future periods. We believe these non-GAAP financial measures are useful to investors because they provide greater transparency with respect to key metrics used by management in its financial and operational decision making and because they are used by our institutional investors and the analyst community to analyze the health of our business.

Non-GAAP operating expenses and non-GAAP operating income – We define non-GAAP operating expenses as operating expenses excluding certain expenses related to the amortization of intangible assets, restructuring, loss on sale of business, corporate transition cost, and acquisition and integration. We define non-GAAP operating income as operating income (loss) excluding the expenses related to the amortization of intangible assets, restructuring, loss on sale of business, corporate transition cost, and acquisition and integration. Acquisition and integration related expenses include costs, which are incurred to affect and integrate business combinations, such as professional fees, certain employee retention and salaries related to integration, severances, contract terminations, travel costs related to knowledge transfer, system conversion costs, and asset impairment charges. We consider these non-GAAP financial measures to be useful metrics for management and investors because they exclude the effect of expenses that are related to acquisitions and restructuring projects. By excluding these expenses, we believe that it is easier for management and investors to compare our financial results over multiple periods and analyze trends in our operations. For example, in certain periods, expenses related to amortization of intangible assets may decrease, which would improve GAAP operating margins, yet the improvement in GAAP operating margins due to this lower expense is not necessarily reflective of an improvement in our core business. There are some limitations related to the use of non-GAAP operating expenses and non-GAAP operating income versus operating expenses and operating income calculated in accordance with GAAP. We compensate for these limitations by providing specific information about the GAAP amounts excluded from non-GAAP operating expense and non-GAAP operating income and evaluating non-GAAP operating expense and non-GAAP operating income together with GAAP operating expense and operating income.

Non-GAAP net income and non-GAAP diluted EPS – We define non-GAAP net income as net income (loss) attributable to Itron, Inc. excluding the expenses associated with amortization of intangible assets, amortization of debt placement fees, debt extinguishment, restructuring, loss on sale of business, corporate transition cost, acquisition and integration, and the tax effect of excluding these expenses. We define non-GAAP diluted EPS as non-GAAP net income divided by diluted weighted-average shares outstanding during the period calculated on a GAAP basis and then reduced to reflect the anti-dilutive impact of the convertible note hedge transaction entered into in connection with the 0% Convertible Notes due 2026 issued in March 2021. We consider these financial measures to be useful metrics for management and investors for the same reasons that we use non-GAAP operating income. The same limitations described above regarding our use of non-GAAP operating income apply to our use of non-GAAP net income and non-GAAP diluted EPS. We compensate for these limitations by providing specific information regarding the GAAP amounts excluded from these non-GAAP measures and evaluating non-GAAP net income and non-GAAP diluted EPS together with GAAP net income attributable to Itron, Inc. and GAAP diluted EPS.

For interim periods the budgeted annual effective tax rate (AETR) is used, adjusted for any discrete items, as defined in Accounting Standards Codification (ASC) 740 - Income Taxes. The budgeted AETR is determined at the beginning of the fiscal year. The AETR is revised throughout the year based on changes to our full-year forecast. If the revised AETR increases or decreases by 200 basis points or more from the budgeted AETR due to changes in the full-year forecast during the year, the revised AETR is used in place of the budgeted AETR beginning with the quarter the 200 basis point threshold is exceeded and going forward for all subsequent interim quarters in the year. We continue to assess the AETR based on latest forecast throughout the year and use the most recent AETR anytime it increases or decreases by 200 basis points or more from the prior interim period.

Adjusted EBITDA – We define adjusted EBITDA as net income (loss) (a) minus interest income, (b) plus interest expense, depreciation and amortization, debt extinguishment, restructuring, loss on sale of business, corporate transition cost, acquisition and integration related expense, and (c) excluding income tax provision or benefit. Management uses adjusted EBITDA as a performance measure for executive compensation. A limitation to using adjusted EBITDA is that it does not represent the total increase or decrease in the cash balance for the period and the measure includes some non-cash items and excludes other non-cash items. Additionally, the items that we exclude in our calculation of adjusted EBITDA may differ from the items that our peer companies exclude when they report their results. We compensate for these limitations by providing a reconciliation of this measure to GAAP net income (loss).

Free cash flow – We define free cash flow as net cash provided by operating activities less cash used for acquisitions of property, plant and equipment. We believe free cash flow provides investors with a relevant measure of liquidity and a useful basis for assessing our ability to fund our operations and repay our debt. The same limitations described above regarding our use of adjusted EBITDA apply to our use of free cash flow. We compensate for these limitations by providing specific information regarding the GAAP amounts and reconciling to free cash flow.

Constant currency – We refer to the impact of foreign currency exchange rate fluctuations in our discussions of financial results, which references the differences between the foreign currency exchange rates used to translate operating results from the entity's functional currency into U.S. dollars for financial reporting purposes. We also use the term "constant currency", which represents financial results adjusted to exclude changes in foreign currency exchange rates as compared with the rates in the comparable prior year period. We calculate the constant currency change as the difference between the current period results and the comparable prior period's results restated using current period foreign currency exchange rates.

The tables below reconcile the non-GAAP financial measures of operating expenses, operating income, net income, diluted EPS, adjusted EBITDA, and free cash flow with the most directly comparable GAAP financial measures.

ITRON, INC.

RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES

TO THE MOST DIRECTLY COMPARABLE GAAP FINANCIAL MEASURES

 

(Unaudited, in thousands, except per share data)

 

TOTAL COMPANY RECONCILIATIONS

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2021

 

2020

 

2021

 

2020

NON-GAAP OPERATING EXPENSES

 

 

 

 

 

 

 

 

GAAP operating expenses

 

$

156,807

 

 

$

183,904

 

 

$

292,911

 

 

$

329,100

 

 

Amortization of intangible assets

 

(8,997

)

 

(11,140

)

 

(17,970

)

 

(22,305

)

 

Restructuring

 

(192

)

 

2,683

 

 

1,788

 

 

2,931

 

 

Loss on sale of business

 

(24,711

)

 

(56,915

)

 

(26,103

)

 

(56,915

)

 

Corporate transition cost

 

 

 

(7

)

 

 

 

33

 

 

Acquisition and integration related expense

 

109

 

 

(338

)

 

486

 

 

(1,610

)

 

Non-GAAP operating expenses

 

$

123,016

 

 

$

118,187

 

 

$

251,112

 

 

$

251,234

 

 

 

 

 

 

 

 

 

 

 

NON-GAAP OPERATING INCOME

 

 

 

 

 

 

 

 

GAAP operating income (loss)

 

$

(6,932

)

 

$

(45,387

)

 

$

24,008

 

 

$

(19,017

)

 

Amortization of intangible assets

 

8,997

 

 

11,140

 

 

17,970

 

 

22,305

 

 

Restructuring

 

192

 

 

(2,683

)

 

(1,788

)

 

(2,931

)

 

Loss on sale of business

 

24,711

 

 

56,915

 

 

26,103

 

 

56,915

 

 

Corporate transition cost

 

 

 

7

 

 

 

 

(33

)

 

Acquisition and integration related expense

 

(109

)

 

338

 

 

(486

)

 

1,610

 

 

Non-GAAP operating income

 

$

26,859

 

 

$

20,330

 

 

$

65,807

 

 

$

58,849

 

 

 

 

 

 

 

 

 

 

 

NON-GAAP NET INCOME & DILUTED EPS

 

 

 

 

 

 

 

 

GAAP net loss attributable to Itron, Inc.

 

$

(33,123

)

 

$

(62,802

)

 

$

(20,520

)

 

$

(54,118

)

 

Amortization of intangible assets

 

8,997

 

 

11,140

 

 

17,970

 

 

22,305

 

 

Amortization of debt placement fees

 

12,695

 

 

963

 

 

15,347

 

 

1,926

 

 

Debt extinguishment

 

10,000

 

 

 

 

11,681

 

 

 

 

Restructuring

 

192

 

 

(2,683

)

 

(1,788

)

 

(2,931

)

 

Loss on sale of business

 

24,711

 

 

56,915

 

 

26,103

 

 

56,915

 

 

Corporate transition cost

 

 

 

7

 

 

 

 

(33

)

 

Acquisition and integration related expense

 

(109

)

 

338

 

 

(486

)

 

1,610

 

 

Income tax effect of non-GAAP adjustments

 

(10,719

)

 

(2,552

)

 

(13,716

)

 

(1,379

)

 

Non-GAAP net income attributable to Itron, Inc.

 

$

12,644

 

 

$

1,326

 

 

$

34,591

 

 

$

24,295

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP diluted EPS

 

$

0.28

 

 

$

0.03

 

 

$

0.79

 

 

$

0.60

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP weighted average common shares outstanding - Diluted

 

45,478

 

 

40,488

 

 

43,731

 

 

40,481

 

 

 

 

 

 

 

 

 

 

ADJUSTED EBITDA

 

 

 

 

 

 

 

 

GAAP net loss attributable to Itron, Inc.

 

$

(33,123

)

 

$

(62,802

)

 

$

(20,520

)

 

$

(54,118

)

 

Interest income

 

(432

)

 

(1,258

)

 

(974

)

 

(1,811

)

 

Interest expense

 

14,004

 

 

11,684

 

 

24,479

 

 

22,961

 

 

Income tax provision (benefit)

 

(216

)

 

4,801

 

 

4,445

 

 

12,351

 

 

Debt extinguishment

 

10,000

 

 

 

 

11,681

 

 

 

 

Depreciation and amortization

 

21,109

 

 

24,199

 

 

42,919

 

 

48,230

 

 

Restructuring

 

192

 

 

(2,683

)

 

(1,788

)

 

(2,931

)

 

Loss on sale of business

 

24,711

 

 

56,915

 

 

26,103

 

 

56,915

 

 

Corporate transition cost

 

 

 

7

 

 

 

 

(33

)

 

Acquisition and integration related expense

 

(109

)

 

338

 

 

(486

)

 

1,610

 

 

Adjusted EBITDA

 

$

36,136

 

 

$

31,201

 

 

$

85,859

 

 

$

83,174

 

 

 

 

 

 

 

 

 

 

 

FREE CASH FLOW

 

 

 

 

 

 

 

 

Net cash provided by operating activities

 

$

72,725

 

 

$

6,892

 

 

$

122,680

 

 

$

25,786

 

 

Acquisitions of property, plant, and equipment

 

(9,064

)

 

(16,447

)

 

(20,476

)

 

(29,049

)

 

Free Cash Flow

 

$

63,661

 

 

$

(9,555

)

 

$

102,204

 

 

$

(3,263

)

 

 

Itron, Inc.
Kenneth P. Gianella
Vice President, Investor Relations
(669) 770-4643

David Means
Director, Investor Relations
(737) 242-8448

Rebecca Hussey
Manager, Investor Relations
(509) 891-3574

Source: Itron, Inc.